Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering With HSP90-EGFR Interaction and Downstream Signaling Pathways

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms21051845
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Inhibition of Gastric Tumor Growth by a Novel Hsp90 Inhibitor

Biochemical Pharmacology
BiochemistryPharmacology
2013English

Hsp90 Inhibitor Induces KG-1a Cell Differentiation and Apoptosis via Akt/NF-κB Signaling

Oncology Reports
MedicineCancer ResearchOncology
2017English

JTC-801 Suppresses Melanoma Cells Growth Through the PI3K‑Akt‑mTOR Signaling Pathways

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Hypoxic Radiosensitization by DMAG, an Hsp90 Inhibitor

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

A Novel PI3K Inhibitor iMDK Suppresses Non-Small Cell Lung Cancer Cooperatively With a MEK Inhibitor

Experimental Cell Research
Cell Biology
2015English

Targeting the Hsp90-Cdc37-Client Protein Interaction to Disrupt Hsp90 Chaperone Machinery

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Combined PI3K/Akt and Hsp90 Targeting Synergistically Suppresses Essential Functions of Alloreactive T Cells and Increases Tregs

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2015English

A Novel Sialyltransferase Inhibitor Suppresses FAK/Paxillin Signaling and Cancer Angiogenesis and Metastasis Pathways

Cancer Research
Cancer ResearchOncology
2011English

Cytosolic PKM2 Stabilizes Mutant EGFR Protein Expression Through Regulating HSP90-EGFR Association

Oncogene
Cancer ResearchGeneticsMolecular Biology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy